Patients with schizophrenia and substance related comorbidity or substance induced psychotic disorder are difficult to treat. Although the prevalence of a ... Marc,Krause,Maximilian,... - 《European Neuropsychopharmacology the Journal of the European College of Neuropsychopharmacology》 被引量: 4发表: ...
[107]. There are very limited studies on the clinical efficacy of cannabinoid use in patients with gastroparesis. This is largely due to the fact that cannabis is currently listed as a Schedule 1 substance, and the US federal law has declared its use, sale, or distribution illegal since the...
M Tohen,F Zhang,PD Feldman,AR Evans,DG Perahia,A Breier 摘要: The involvement of substance P (SP) in cardiovascular regulatory mechanisms was investigated in the nucleus of the tractus solitarius (nTS) of urethane-anesthetized Wistar rats. Unilateral microinjections of SP (0.25 pmol in 50 nl...
Almeida 摘要: J Clin Psychiatry. 1998 Jul;59(7):380-1. Case Reports; Letter 关键词: Humans Dyskinesia, Drug-Induced Substance Withdrawal Syndrome Haloperidol Benzodiazepines Pirenzepine Antipsychotic Agents Schizophrenia Aged Biperiden DOI: 10.4088/JCP.v59n0707a 被引量: 76 年份: 1998 ...
Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study. 2003. Attenuation of olanzapine- induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study. Am J ... M Poyuro...
Neuropsychiatric Disease and Treatment Dovepress open access to scientific and medical research Open Access Full Text Article Original Research Olanzapine–valproate combination versus olanzapine or valproate monotherapy in the treatment of bipolar I mania: a randomized controlled study in a Chinese ...
with the exceptions of olanzapine-fluoxetine combination and quetiapine. A review of the positive studies of acute treatment for bipolar depression based on evidence from large, randomized, double-blind, placebo-controlled studies can be found elsewhere in the literature[58]. Olanzapine-fluoxetine and ...
5. Mindfulness Based Relapse Prevention and the matrix model in substance abuse relapse prevention. [D] . Uhlig, Douglas J. 2009 机译:基于正念的预防复发和预防药物滥用复发的矩阵模型。 6. Enhanced relapse prevention for bipolar disorder – ERP trial. A cluster randomised controlled trial to ass...
In a 12-week, double-blind, placebo controlled trial, 40 BPD patients (25 female, 15 male) were randomly assigned to receive olanzapine (n=20) or placebo (n =20). These patients were rated as moderately ill based on an average Clinical Global Impressions scale (CGI) score of 4.3 and ...
Detke, DelBello, Landry, and Usher (2015) published the results of a study using a combination of olanzapine and fluoxetine, known as combination OFC (brand name Symbyax), to treat acute depressive symptoms in youth. This was an 8-week randomized, double-blind, placebo-controlled ...